| CTRI Number |
CTRI/2026/02/104387 [Registered on: 20/02/2026] Trial Registered Prospectively |
| Last Modified On: |
09/05/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Other (Specify) [Qigong and Yoga] |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
Comparative Effect of Yoga and Qigong on Muscle strength Muscle mass Physical performance and Frailty in Older adults with weak bones and Muscles |
|
Scientific Title of Study
|
Comparative Effect of Yoga and Qigong on Muscle strength Muscle mass Physical Performance and Frailty in Older adults with Osteosarcopenia A Randomized Clinical Trial |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Basavjyoti Rajshekhar Lokapure |
| Designation |
Postgraduate student (Orthopedic Physiotherapy) |
| Affiliation |
KLES Institute of Physiotherapy Belgaum |
| Address |
KLES Dr. Prabhakar Kore Hospital and MRC, Advanced Physiotherapy Centre Orthopedic Physiotherapy Department Room no.18 Nehru Nagar, Belgaum 590010
Belgaum
KARNATAKA
590010
INDIA
Belgaum KARNATAKA 590010 India |
| Phone |
9503058834 |
| Fax |
|
| Email |
jyotilokapure678@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Peeyoosha Gurudat |
| Designation |
Professor and Head of Department |
| Affiliation |
KLES Institute of Physiotherapy Belgaum |
| Address |
KLES Dr. Prabhakar Kore Hospital and MRC, Advanced Physiotherapy Centre Orthopedic Physiotherapy Department Room no.18 Nehru Nagar, Belgaum 590010
Belgaum
KARNATAKA
590010
INDIA
Belgaum KARNATAKA 590010 India |
| Phone |
9844821355 |
| Fax |
|
| Email |
peeyooshagurudat@klekipt.edu.in |
|
Details of Contact Person Public Query
|
| Name |
Dr Peeyoosha Gurudat |
| Designation |
Professor and Head of Department |
| Affiliation |
KLES Institute of Physiotherapy Belgaum |
| Address |
KLES Dr. Prabhakar Kore Hospital and MRC, Advanced Physiotherapy Centre Orthopedic Physiotherapy Department Room no.18 Nehru Nagar, Belgaum 590010
Belgaum
KARNATAKA
590010
INDIA
Belgaum KARNATAKA 590010 India |
| Phone |
9844821355 |
| Fax |
|
| Email |
peeyooshagurudat@klekipt.edu.in |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
Basavjyoti Rajshekhar Lokapure |
| Address |
KAHER Institute of Physiotherapy, Nehru Nagar, Belgaum, Karnataka-590010 |
| Type of Sponsor |
Other [[self]] |
|
|
Details of Secondary Sponsor
|
| Name |
Address |
| Dr Peeyoosha Gurudut |
KAHER Institute of Physiotherapy, Nehru Nagar, Belgaum, Karnataka - 590010 |
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Basavjyoti Rajshekhar Lokapure |
KLE Dr. Prabhakar Kore Hospital and MRC, Advanced Physiotherapy Centre |
KLES Dr. Prabhakar Kore Hospital and MRC, Advanced Physiotherapy Centre Orthopedic Physiotherapy Department Room no.18 Nehru Nagar, Belgaum 590010
Belgaum
KARNATAKA
590010
INDIA Belgaum KARNATAKA |
09503058834
jyotilokapure678@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Research and Ethical Committe, KLEU Institute of Physiotherapy, Belgaum |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: M958||Other specified acquired deformities of musculoskeletal system, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Qigong |
Participants will receive qigong training for 6 weeks. All interventions will be administered for 6 weeks by a trained physiotherapist. 3 sessions per week, administered for 6 weeks by a trained physiotherapist. |
| Intervention |
Yoga |
Participants will receive yoga training for 6 weeks. All the interventions will be administered for 6 weeks by a trained physiotherapist. 3 sessions per week, administered for 6 weeks by a trained physiotherapist. |
|
|
Inclusion Criteria
|
| Age From |
60.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Both |
| Details |
1. Older Adults 60 to 70 years.
2. Diagnosis of Sarcopenia according to the Asian Working Group for Sarcopenia (AWGS 2019) consensus criteria:
1. Low Muscle Strength (Hand-grip strength less than 28kg for men and less than 18 kg for women.
2. Low Muscle quantity/quality-Bioelectric Impedance Analysis (Men less than 7.0 kg per meter square and Women less than 5.7 kg per meter square.
3. SPPB less than 8, TUG more than 20 seconds,4m walk more than 6 minutes.
3. Frailty Score less than 6 on the clinical frailty scale.
4. Medically stable and able to provide informed consent. |
|
| ExclusionCriteria |
| Details |
1. Individuals with acute or unstable cardiovascular, respiratory, or metabolic conditions.
2. History of neurological disorders that severely affect movement.
3. Musculoskeletal conditions that severely contraindicate physical exercise.
4. Current participation in other structured exercise programs.
5. Diagnosis of dementia or severe cognitive impairment. |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
1. Muscle strength is measured by using a Handheld Dynamometer.
2. Muscle Mass is measured by using BIA.
3. Physical performance is measured by using the Short Physical Performance Battery. |
1. Muscle strength will be assessed pre-intervention and post-intervention over six weeks.
2. Muscle Mass will be assessed pre-intervention and post-intervention over six weeks.
3. Physical performance will be assessed pre-intervention and post-intervention over six weeks. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| 1. Frailty measured using a Fried Frailty Phenotype Scale. |
1. Frailty will be assessed pre-intervention & post-intervention, over six weeks. |
|
|
Target Sample Size
|
Total Sample Size="46" Sample Size from India="46"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
02/03/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Open to Recruitment |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Comparative effect of yoga and qigong on muscle strength, muscle mass, physical performance, and frailty in older adults with osteosarcopenia is an emerging area of interest in geriatric rehabilitation. Osteosarcopenia, characterized by the coexistence of low bone mass and reduced muscle mass and function, significantly increases the risk of falls, fractures, and functional decline in older adults. Both yoga and qigong are mind–body exercises known to improve balance, strength, and overall physical performance; however, evidence directly comparing their effects in individuals with osteosarcopenia is limited. This randomized controlled trial aims to compare the effects of yoga and qigong on muscle strength, muscle mass, physical performance, and frailty in older adults aged 60–70 years with osteosarcopenia. A total of 46 participants will be randomly allocated into two groups: one group receiving yoga intervention and the other receiving qigong intervention. The interventions will be administered for a specified duration under supervision, and outcomes will be assessed before and after the intervention period using validated measurement tools. The findings of this study may help identify an effective exercise strategy for improving musculoskeletal health and reducing frailty in this population. |